Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) is a clinical trial[1].
Key Facts
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) is in the country of Canada[2].
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)'s instance of is recorded as clinical trial[3].
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)'s start time is recorded as +2017-10-06T00:00:00Z[4].
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)'s end time is recorded as +2021-09-30T00:00:00Z[5].
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)'s contributor to the creative work or subject is recorded as Bristol-Myers Squibb[6].
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)'s contributor to the creative work or subject is recorded as Hoffmann-La Roche[7].
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)'s main subject is recorded as multiple myeloma[8].
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)'s number of participants is recorded as {'unit': '1', 'amount': '+720'}[9].
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)'s title is recorded as Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR): A Phase II Basket Trial[10].
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)'s short name is recorded as CAPTUR[11].
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[12].
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)'s ClinicalTrials.gov ID is recorded as NCT03297606[13].
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)'s research intervention is recorded as dasatinib[14].
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)'s research intervention is recorded as sirolimus[15].
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)'s research intervention is recorded as vemurafenib[16].
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)'s research intervention is recorded as pertuzumab[17].
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)'s clinical trial phase is recorded as phase II clinical trial[18].
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)'s research site is recorded as BC Cancer Agency[19].
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)'s study type is recorded as interventional study[20].